Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$6.61 USD
+0.04 (0.61%)
Updated Jul 25, 2024 04:00 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Adherex Technologies Inc. [FENC]
Reports for Purchase
Showing records 41 - 60 ( 106 total )
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Will FDA Make FENC Thankful Come Thanksgiving?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK New Drug Application Resubmitted; Adjusting PT to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Receives FDA Complete Response Letter, Resubmission Timelines Unclear
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
2Q20 Financials; PEDMARK PDUFA Date Ahead August 10
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
1Q20 Financials; Cash Replenished; Modulating PT to $15
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Application Accepted; Priority Review, as Expected; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK NDA Filing Accepted; Approval Anticipated by August 10 PDUFA Date
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D